PATENT CLAIM ANALYSIS

Application Number: 16090072
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-05
Patent Classification: ["544", "238000"]

Abstract:
The present invention relates to a novel pyrimidine-4-carboxylic acid derivative having an anticancer activity, and the compound of the present invention is useful as a drug for treating and preventing tumor diseases.

Claim (Index 10):
The theoretical agent according to  claim 9 , wherein the tumor disease is selected from the group consisting of prostate cancer, breast cancer, bladder cancer, lung cancer, and melanoma.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 97.0
- Lexical Diversity: 1.17241
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15689115', '14475762', '14923525', '14775405', '14994824']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7770126230008705
- 35 USC 102 Novelty (BERT): 0.5224234604747716
- Combined Prediction Score: 0.7515537067482606
- Mean Citation Score: 255.124242
- Max Citation Score: 261.55322
- Similarity Product: 136.72977274457335

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test